Corlieve Therapeutics SAS Closes Seed Financing to Develop Therapies for Severe Neurological Conditions

PARIS, Nov. 2, 2020 -- (Healthcare Sales & Marketing Network) -- Corlieve Therapeutics today announced the closing of its seed financing led by Kurma Partners and IDinvest Partners, together with Pureos Bioventures. Corlieve is focused on developing novel... Regenerative Medicine, Neurology, Venture Capital Corlieve Therapeutics, gene therapy, temporal lobe epilepsy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news